Piroxicam and ovarian changes in adult goat
PDF (Español (España))

Keywords

Reproducción
cabras
prostaglandinas
inhibidor de COX-2
AINE Reproduction
Goats
prostaglandins
COX-2 inhibitor
AINE

How to Cite

Miranda Jiménez, L. (2016). Piroxicam and ovarian changes in adult goat. Nova Scientia, 8(16), 91–105. https://doi.org/10.21640/ns.v8i16.375

Abstract

Ovarian function can be altered by ciclooxigense enzyme inhibitors (COX). Piroxicam administration, a COX inhibitor, is an usual veterinary drug and it can alter the function of the ovaries.The aim of this research was to evaluate the intra and extra-ovarian changes in adult goats as a response to piroxicam. Six adult goats (35 to 40 kg of body weight) were used. Estrus synchronization and ovulation were induced by CIDR (controlled release device intravaginal progesterone) insertion through 11 days, when the CIDR was removed prostaglandin F2α and 400 IU of eCG (ovulation induction) were applied. Before (24 h) ovulation induction, the goats in the control (n = 3) and treatment group (n = 3) were intramuscularly treated with one mL of saline solution or piroxicam (1.5 mg-1 kg of body weight), respectively, in four applications with 24 h interval. After the first piroxicam application (144 h) ovaries were removed. Blood sampling was performed from 48 hours before ovulation induction until ovariectomy was performed. In left and right ovary surface, both number and size of follicles and corpora lutea were quantified. In 16 histological sections from each ovary, the same intraovarian structures were evaluated. Also both serum progesterone (P4) and estradiol (E2) were determined. Follicles and CL were analyzed through Wilcoxon rank sum test. While, E2 and P4 were analyzed using models for repeated measures (linear mixed models), which were fitted using the R statistical software. Differences were took at α< 0.05. Piroxicam administration reduces intraovarian follicular number (P< 0.0001) and development of intraovarian CL (P=0.04). Levels of E2 and P4 were not modified by piroxicam application (P=0.2), although, P4 concentration showed elevation, coincident with the time of ovulation induction (P=0.002), but not by treatment. Follicular alterations may be an alternative route that piroxicam and other AINE used to inhibit ovulation frequently reported with this drug treatments.

https://doi.org/10.21640/ns.v8i16.375
PDF (Español (España))

References

Akil M., R.S. Amos and Stewart P. (1996). Infertility may sometimes be associated with NSAID consumption. British Journal of Rheumatology. 35: 76-78.

Arosh J.A., S.K. Banu., S. Kimmins., P. Chapdelaine., L. A. Maclaren and Fortier M.A. (2004). Effect of interferon-tau on prostaglandin biosynthesis, transport, and signaling at the time of maternal recognition of pregnancy in cattle: evidence of polycrine actions of prostaglandin E2. Endocrinology. 145(11): 5280-93.

Bata M.S., M. Al-Ramahi., A.S. Salhab., M.N. Gharaibeh and Schwartz J. (2006). Delay of ovulation by meloxicam in healthy cycling volunteers: a placebo controlled, double blind, crossover study. Journal Clinics Pharmacology. 46: 925-932.

Costa L.O.B., M.C. Mendes., R.A. Ferriani., M.D. Moura., R.M. Reis and Silva de Sá M.F. (2004). E2 and testosterone concentrations in follicular fluid as criteria to discriminate between mature and immature oocytes. Brazilian Journal of Medical and Biology Research. 37: 1747-1755.

Dubois R.N., S.B. Abramson., L. Crofford., R.A. Gupta., L.S. Simon., L.B. Van De Putte and Lipsky P.E. (1998). Cyclooxygenase in biology and disease. Federetion of American Societies for Esperimental Biology Journal. 12: 1063-1073.

Fatum M., Y. Gyo., P. Diana., N. Laufer and Simon A. (2006). Is E2 mandatory for an adequate folicular and embryo development? A mouse model using aromatase inhibitor (anastrozole). Journal of Assisted Reproduction Genetics. 23: 407-412.

Frandson R.D., W.W. Lee and Dee F.A. (2009). Anatomy and physiology of farm animals. 7th ed. 434-435. Iowa, USA: Wiley-Blackwell .

Garverick H.A., W.G. Zollers and Smith M.F. (1992). Mechanisms associated with corpus luteum lifespan in animals having normal or subnormal luteal function. Animal Reproduction. Science. 28: 111-124.

Gaytán M., C. Bellido., C. Morales., J.E. Sánchez-Criado and Gaytán F. (2006). Effects of selective inhibition of cyclooxygenase and lipooxygenase pathways in follicle rupture and ovulation in the rat. Reproduction. 132: 571-577.

Goff A.K. (2004). Steroid hormone modulation of prostaglandin secretion in the ruminant endometrium during the estrous cycle. Biology Reproduction. 71: 11-16.

Gonzalez de Bulnes A., M.J. Santiago., B.A. Gómez and López S.A. (2000). Relationship between ultrasonographic assessment of the corpus luteum and plasma progesterone concentration during the oestrous cycle in monovular ewes. Reproduction Domestic Animals. 35: 65-68.

INEGI (Instituto Nacional de Estadística y Geográgia). (2009). Prontuario de información geográfica municipal de los Estados Unidos Mexicanos, Salinas San Luis Potosi. http://www3.inegi.org.mx/sistemas/mexicocifras/datos-geograficos/24/24025.pdf. (5 de junio de 2015).

Jabbour H.N. and Sales K.J. (2004). Prostaglandin receptor signalling and function in human endometrial pathology. Trends in Endocrinology and Metabolism. 15(8): 398-404.

Jabbour H.N., K.J. Sales., S.C. Boddy., R.A. Anderson and Williams A.R.W. (2005). A positive feedback loop that regulates cyclooxygenase-2 expression and prostaglandin F2α synthesis via the F-series-prostanoid receptor and extracellular signal-regulated kinase 1/2 signaling pathway. Endocrinology. 146(11): 4657-4664.

Jesam C., A.M. Salvatierra., J.L. Schwartz and Croxatto H. B. (2010). Suppression of follicular rupture with meloxicam, a cyclooxygenase-2 inhibitor: potential for emergency contraception. Human Reproduction. 25(2): 368-373.

Kawaguchi S., A. Bowolaksono., S. Yoshioka., R. Sakumoto., Okuda K. (2013). Luteoprotective mechanisms of prostaglandin F2α stimulated by luteinizing hormone in the bovine corpus luteum. Journal Reproduction Development. 59(3): 225-30.

Kowalewski M.P., S. Ihle., M.J. Siemieniuch., A. Gram., A. Boos., S. Zduńczyk., J. Fingerhut., B. Hoffmann., G.A. Jurczak., A. Domosławska and Janowski T. (2015). Formation of the early canine CL and the role of prostaglandin E2 (PGE2) in regulation of its function: An in vivo approach. Theriogenology. 1: 1-10.

Langenbach R., S.G. Morham., H.F. Tiano., C.D. Loftin., B.I. Ghanayem., P.C. Chulada., J.F. Mahler., C.A. Lee., E.H. Goulding., K.D. Kluckman., H.S. Kim and Smithies O. (1995). Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell. 83: 483-492.

Langenbach R., C.D. Loftin., C. Lee and Tiano H. (1999). Cyclooxygenase-deficient mice. A summary of their characteristics and susceptibilities to inflammation and carcinogenesis. Annals of New York Academy of Sciences. 889: 52-61.

Lim H., B.C. Paria., S.K. Das., J.E. Dinchuk., R. Langenbach., J.M. Trzaskos and Dey S. K. (1997). Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell. 91: 197-208.

Murphy B.D. (2000). Models of luteinization. Biology of Reproduction. 63: 2-11.

Myles, H. and Douglas A.W. (1973). Nonparametric statistical methods. New York. 115-120. John Wiley & Sons.

Pall M., B.E. Fridén and Brännström M. (2001). Induction of delayed follicular rupture in the human by the selective COX-2 inhibitor rofecoxib: a randomized double-blind study. Human Reproduction. 16(7): 1323-1328.

R Core Team. (2015). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org/.

Ricciotti E. and FitzGerald G.A. (2011). Prostaglandins and inflammation. Arteriosclerosis Thrombosis and Vascular Biology. 31(5): 986-1000.

Rogan R.L., M.J. Murphy., R.L. Stouffer and Hennebold J.D. (2008). Prostaglandin synthesis, metabolism, and signaling potential in the rhesus macaque corpus luteum throughout the luteal phase of the menstrual cycle. Endocrinology. 149(11): 5861-71.

Ross H.M. y Bojciech P. (2007). Técnica histológica y microscopia en histologia texto y atlas color con biología celular molecular, 5ª ed. 975. Médica Panamericana. Buenos Aires, Argentina.

Salhab A.S., B.I. Amro and Shomaf M.S. (2003). Further investigation on meloxicam contraceptivity in female rabbits: luteinizing unruptured follicles, microscopic evidence. Contraception. 67: 485-489.

Sirois J., J. Liu., D. Boerboom and Antaya M. (2000). Prostaglandins and ovulation: from indomethacin to PGHS-2 knockout. In Adashi EY Ovulation: Evolving Scientific and Clinical Concepts. Springer. New York. pp 208-220.

Sirois J., K. Sayasith., K.A. Brown., A.E. Stock., N. Bouchard and Doré M. (2004). Cyclooxygenase-2 and its role in ovulation: a 2004 account. Hum Reproduction Update. 10(5): 373-385.

Smith W.L. and DeWitt D.L. (1996). Prostaglandin endoperoxide H synthase-1 and -2. Advances in Immunology. 62: 167-215.

Sousa C.J.H., B.K. Campbell and Bair D.T. (1997). Follcular dynamics

and ovarian steroid secretion in sheep during the follicular and early luteal phase of the estrous cycle. Biology of Reproction 56: 483-488.

Stouffer R.L. (2006). Structure, function, and regulation of the corpus luteum. Physiology of Reproduction. vol. 1, 3a. ed., pp: 475-526.

Stouffer R.L., C.V. Bishop., R.L. Bogan., F. Xu and Hennebold J.D. (2013). Endocrine and local control of the primate corpus luteum. Reproductive Biology. 13(4): 259-271.

Tolentino C.C., J.L. Miranda., C.A. Quero y Pescador S.N. (2015). Frecuencia, morfología y concentración de progesterona in vitro de cuerpos luteos cavitarios de ovejas. Agrociencia. 49: 267-265.

Walters K.A. (2015) Role of androgens in normal and parthological ovarian function. Reproduction. 149: R193-R218.

Wu Y.L. and Wiltbank M.C. (2001). Transcriptional regulation of cyclooxygenase-2 gene in ovine large luteal cells. Biology Reproduction. 65: 1565-1572.

Zhang H., B. Von Schoultz., J.M. Cline and Sahlin L. (2011). Distribution of cyclooxygenase -1 and -2 in uterus and breast from cynomolgus monkeys effects of hormone treatment. Menopause. 18(9): 1001-1009.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2016 Nova Scientia